Keywords: genelabs, lupus, drug, effective, phase, iii, technologies

Genelabs lupus drug effective in Phase III

Article | 22 September 1999

Genelabs Technologies has reported positive results in its second PhaseIII trial of GL701 (prasterone) in patients with systemic lupus erythematosus, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Nystatin

Go to drug listing